Attapulgite 40 mg/ml Oral Suspension is a compounded formulation designed to treat a range of gastrointestinal conditions. These include diarrhea, constipation, irritable bowel syndrome, gastroenteritis, and dyspepsia. The medication is a liquid dosage form, ensuring a uniform dispersion of ingredients for effective administration.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present the compounded formulation of Attapulgite 40 mg/ml Oral Suspension, a versatile medication designed to address a range of health conditions. This oral suspension is a liquid dosage form where the active ingredient, attapulgite, is uniformly dispersed throughout a liquid medium, ensuring a consistent and homogeneous mixture for administration.
Attapulgite, a clay mineral with a long history of medicinal use, is the key component of this formulation. It has demonstrated efficacy in managing conditions such as diarrhea, constipation, and irritable bowel syndrome.
This formulation is designed for ease of use and is generally well-tolerated by most patients. It is available in a strength of 40 mg/ml and can be consumed with or without food, as per individual preference or dietary requirements. The typical recommended dosage is 40 mg/ml, to be taken orally once or twice daily, depending on the specific instructions provided by the healthcare provider.
Attapulgite 40 mg/ml Oral Suspension is a potent and safe treatment option for a variety of health conditions. It is important for patients to adhere to their doctor's instructions while using this medication. For any queries or concerns regarding this formulation, please feel free to contact us at Bayview Pharmacy. We are committed to providing comprehensive information and support to ensure optimal patient care and treatment outcomes.
Attapulgite 40 mg/ml Oral Suspension is a compounded formulation that may interact with a variety of other medications. These include, but are not limited to, antacids, antibiotics, and antidiarrheal agents. It is crucial for patients to inform their healthcare provider of all medications they are currently taking, including over-the-counter medications, vitamins, and herbal supplements. This is to ensure awareness of any potential drug-drug interactions.
Furthermore, Attapulgite 40 mg/ml Oral Suspension is used to treat a range of gastrointestinal conditions such as diarrhea, constipation, irritable bowel syndrome, Crohn's disease, and ulcerative colitis. It is important to note that this medication may interact with other drugs used to treat these conditions, including corticosteroids, immunosuppressants, and biologic agents.
Patients should also be aware that Attapulgite 40 mg/ml Oral Suspension may interact with medications used to treat other conditions. These include anticoagulants, antihypertensives, and anticonvulsants. Additionally, it may interact with medications used to treat infections, such as antibiotics and antifungals, as well as medications used to treat allergies, such as antihistamines and decongestants.
Understanding these potential interactions is crucial for appropriate treatment. If you have any questions or concerns about the interactions of Attapulgite 40 mg/ml Oral Suspension, please consult with your healthcare provider.
Attapulgite 40 mg/ml Oral Suspension is a compounded formulation designed for oral administration. It is primarily used to manage a variety of disease states, particularly those related to gastrointestinal issues such as diarrhea and constipation. The active ingredient, Attapulgite, is a clay-like material that is insoluble in water. Its unique properties allow it to absorb toxins and other substances from the gastrointestinal tract, thereby alleviating associated symptoms.
When administered orally, Attapulgite 40 mg/ml Oral Suspension forms a gel-like substance within the stomach and intestines. This gel-like substance serves as a toxin absorber, reducing the symptoms associated with various disease states. Additionally, it helps to mitigate inflammation and irritation within the gastrointestinal tract, further contributing to symptom relief.
Attapulgite 40 mg/ml Oral Suspension is typically administered once or twice daily, depending on the severity of the disease state being treated. It is crucial to adhere to the dosage instructions provided by your healthcare provider to ensure optimal results. To prevent dehydration, it is also recommended to consume ample fluids while on this medication.
If you have any queries regarding Attapulgite 40 mg/ml Oral Suspension or its mechanism of action in treating your specific disease state, do not hesitate to seek clarification. It is essential to understand your treatment options fully to make informed decisions about your health.
Attapulgite 40 mg/ml Oral Suspension is a liquid dosage form of medication. It contains one or more ingredients that are uniformly dispersed throughout a liquid medium, providing a homogeneous mixture for administration.
Attapulgite is an absorbent that works by absorbing bacteria and toxins in the stomach and intestines. This helps to reduce the frequency and severity of diarrhea.
This medication should be taken orally as directed by your healthcare provider. The dosage is based on your medical condition and response to treatment.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Take your next dose at the regular time. Do not double the dose to catch up.
Common side effects may include constipation and stomach cramps. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.
Attapulgite can interact with other medications and may affect how they work. It is important to inform your healthcare provider about all the products you use including prescription drugs, nonprescription drugs, and herbal products before starting treatment with this product.
Consult your healthcare provider before using this medication if you are pregnant, planning to become pregnant, or are breastfeeding. The risks and benefits should be discussed with your healthcare provider.
Store this medication at room temperature, away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call emergency services immediately. Otherwise, call a poison control center right away.
It is generally recommended to avoid alcohol while taking this medication as it may increase the risk of side effects. Always consult your healthcare provider for personalized advice.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally